Brandinium

Trademark search for:

BELIXOS

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2009-05-27 — Application filed
  • 2009-08-06 — Sn assigned for sect 66a appl from ib
  • 2009-08-07 — Application filed
  • 2009-08-11 — Application filed
  • 2009-08-27 — Assigned to examiner
  • 2009-09-03 — Final disposition recorded
  • 2009-09-04 — Office action issued
  • 2009-09-04 — Office action issued
  • 2009-09-04 — Office action issued
  • 2009-09-18 — Correction transaction received from ib
  • 2009-09-23 — Correction from ib entered - no review required
  • 2009-09-29 — Office action issued
  • 2009-11-06 — Limitation of goods received from ib
  • 2009-11-24 — Teas change of correspondence received
  • 2009-11-24 — Office action issued
  • 2009-12-11 — Approved for pub - principal register
  • 2009-12-11 — Teas/email correspondence entered
  • 2009-12-11 — Applicant/correspondence changes (non-responsive) entered
  • 2009-12-11 — Assigned to lie
  • 2009-12-11 — Correspondence received in law office
  • 2009-12-14 — Law office publication review completed
  • 2010-01-19 — Published for opposition
  • 2010-01-19 — Official gazette publication confirmation e-mailed
  • 2010-04-06 — Registered-principal register
  • 2010-07-07 — Final disposition recorded
  • 2010-07-28 — Limitation from the ib examined, no action is needed
  • 2010-07-28 — Final disposition recorded
  • 2010-07-28 — Final disposition recorded
  • 2012-09-28 — Limitation of goods received from ib
  • 2012-10-04 — Correction under section 7 - processed
  • 2012-10-04 — Limitation from the ib examined and entered
  • 2012-10-04 — Assigned to paralegal
  • 2013-02-07 — Final disposition recorded
  • 2013-06-04 — Partial invalidation of reg ext protection created
  • 2014-04-30 — Invalidation reviewed - no action required by office
  • 2014-07-04 — Limitation of goods received from ib
  • 2014-07-23 — Limitation from the ib examined and entered
  • 2014-07-24 — Correction under section 7 - processed
  • 2014-07-24 — Assigned to paralegal
  • 2015-03-24 — Partial invalidation of reg ext protection created
  • 2015-07-15 — Invalidation reviewed - no action required by office
  • 2015-08-27 — Teas change of correspondence received
  • 2015-08-28 — Teas change of correspondence received
  • 2015-11-28 — Teas section 71 received
  • 2016-01-08 — Case assigned to post registration paralegal
  • 2016-01-08 — Registered-sec.71 accepted
  • 2016-01-08 — Notice of acceptance of sec. 71 - e-mailed
  • 2016-09-08 — Partial invalidation of reg ext protection created
  • 2016-09-08 — Partial invalidation of reg ext protection sent to ib
  • 2016-09-08 — Invalidation processed
  • 2017-05-12 — Teas change of correspondence received
  • 2017-05-12 — Partial invalidation processed by the ib
  • 2019-04-06 — Courtesy reminder - sec. 71 (10-yr) e-mailed
  • 2019-06-13 — International registration renewed
  • 2021-02-26 — Cancelled section 71
  • 2021-02-26 — Final status recorded
  • 2021-10-26 — Total invalidation of reg ext protection created
  • 2021-12-18 — Invalidation processed
  • 2021-12-19 — Total invalidation of reg ext protection sent to ib
  • 2022-01-15 — Total invalidation processed by the ib

Owner Information

Biofrontera Pharma GmbH
51377 Leverkusen DE
Biofrontera Pharma GmbH
DE
Biofrontera Pharma GmbH
DE

Correspondent

JENNIFER FRASER Dykema Gossett PLLC
1301 K Street, NW
Suite 1100 West
Washington, DC 20005

Filing Details

Filing Date:
2009-05-27
Status Date:
2021-02-26
Category:
Pharmaceuticals
Filing Year:
2009

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.